|
Bausch & Lomb Stage: LBOs and Special Situations Date of Investment: 2007 Web Site : http://www.bausch.com
|
 |
Bausch & Lomb, based in Rochester, NY, was founded in 1853 and is one of the oldest continually operating companies in the US. The Company has one of the best known healthcare brands in the world and offers one of the most comprehensive product portfolios in the ophthalmic industry, with leading market positions in several major product categories and products available in over 100 countries. The Company‘s core businesses include contact lenses and lens care solutions, as well as ophthalmic surgical and pharmaceutical products.
In October 2007, Warburg Pincus led the acquisition of Bausch & Lomb, which had previously been a publicly traded NYSE company. In February 2008, Warburg Pincus helped Bausch & Lomb acquire eyeonics, the developer and marketer of the crystalens intraocular lens (IOL), the first and only FDA-approved accommodating IOL for the treatment of cataracts. In March 2010, Warburg Pincus recruited Fred Hassan, former Chairman and CEO of Schering-Plough, as the new Chairman of Bausch & Lomb, and Brent Saunders, former President of Global Consumer Health at Schering-Plough as the new Chief Executive Officer of Bausch & Lomb.
